Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: results from the Danish Renal Cancer Group (DARENCA) study-2 - Soerensen, A V; Donskov, F; Hermann, G G (Eur J Cancer, 2014)
et al.